Spots Global Cancer Trial Database for advanced gastrointestinal malignancies
Every month we try and update this database with for advanced gastrointestinal malignancies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C | NCT01577758 | Advanced Gastro... | MLN0264 | 18 Years - | Takeda | |
BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | NCT00207051 | Colorectal Canc... | Brivanib + Cetu... | 18 Years - | Bristol-Myers Squibb | |
Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors | NCT00660426 | Advanced Gastro... Solid Tumors | Oxaliplatin Gemcitabine Capecitabine | 18 Years - | Washington University School of Medicine | |
Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies | NCT00300027 | Gastrointestina... | BMS-582664 | 18 Years - 65 Years | Bristol-Myers Squibb | |
BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | NCT00207051 | Colorectal Canc... | Brivanib + Cetu... | 18 Years - | Bristol-Myers Squibb |